These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7650288)

  • 1. Treatment of AIDS with drugs targeted to inhibit different stages of the HIV life cycle.
    Sarin PS; Goldstein AL
    Immunopharmacol Immunotoxicol; 1995 May; 17(2):217-45. PubMed ID: 7650288
    [No Abstract]   [Full Text] [Related]  

  • 2. GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.
    Agrawal S; Tang JY
    Antisense Res Dev; 1992; 2(4):261-6. PubMed ID: 1363378
    [No Abstract]   [Full Text] [Related]  

  • 3. [Breakthrough in AIDS research--new group of more potent and more selective anti-AIDS compounds].
    Schweiz Rundsch Med Prax; 1990 Apr; 79(15):476-7. PubMed ID: 2336503
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure and biological activity correlation for some nucleoside analogues-inhibitors of reproduction of human immunodeficiency virus (HIV-1).
    Gurskaya GV; Bochkarev AV; Tsapkina EN; Zdanov AS; Krayevsky AA
    Nucleic Acids Symp Ser; 1991; (24):241. PubMed ID: 1841310
    [No Abstract]   [Full Text] [Related]  

  • 5. Researchers seek new class of AIDS drugs.
    Richardson M
    Tex Med; 1992 Jun; 88(6):30. PubMed ID: 1615439
    [No Abstract]   [Full Text] [Related]  

  • 6. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Variants of HIV-2 and HIV-2 and approaches for chemotherapy of HIV infection].
    Rübsamen-Waigmann H
    Offentl Gesundheitswes; 1989; 51(8-9):562-6. PubMed ID: 2531353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy other than reverse transcriptase inhibitors for HIV infection.
    Kaplan JC; Hirsch MS
    Clin Lab Med; 1994 Jun; 14(2):367-91. PubMed ID: 7523020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The present and future of AIDS chemotherapy].
    Stanková M
    Cas Lek Cesk; 1993 Jun; 132(11):321-8. PubMed ID: 8339310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapeutic approaches for the treatment of AIDS.
    Oberg B
    Arzneimittelforschung; 1988 Feb; 38(2):325-6. PubMed ID: 3370082
    [No Abstract]   [Full Text] [Related]  

  • 11. New strategies for treating AIDS.
    Sandstrom PA; Folks TM
    Bioessays; 1996 May; 18(5):343-6. PubMed ID: 8639156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 drug resistance. Molecular pathogenesis and laboratory monitoring.
    D'Aquila RT
    Clin Lab Med; 1994 Jun; 14(2):393-422. PubMed ID: 7523021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future hope? Antiretroviral therapy to treat HIV.
    Santangelo J; Large KM
    Todays OR Nurse; 1989 Oct; 11(10):27-32. PubMed ID: 2683256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in targeted therapy against human immunodeficiency virus [corrected].
    Broder S
    Crit Care Med; 1990 Feb; 18(2 Suppl):S118-25. PubMed ID: 2298027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Attempts at the treatment of acquired immunodeficiency syndrome (AIDS)].
    Turek-Urasińska K
    Pol Tyg Lek; 1987 Dec; 42(49):1551-3. PubMed ID: 3330216
    [No Abstract]   [Full Text] [Related]  

  • 16. [More drugs against HIV/AIDS will soon be available as a review over the drug development shows].
    Oberg B
    Lakartidningen; 1991 Nov; 88(48):4139-42. PubMed ID: 1956253
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in HIV/AIDS therapy.
    Johnson SC; Gerber JG
    Adv Intern Med; 2000; 45():1-40. PubMed ID: 10635044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
    Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
    Korth MJ; Taylor MD; Katze MG
    Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of HIV inhibition by modified antisense oligonucleotides.
    Abramova T; Blinov V; Vlassov V; Gorn V; Zarytova V; Ivanova E; Konevets D; Plyasunova O; Pokrovsky A; Sandakhchiev L
    Nucleic Acids Symp Ser; 1991; (24):283. PubMed ID: 1841341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.